{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:45:56Z","timestamp":1794015956596,"version":"4.8.0"},"reference-count":48,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The antifungal susceptibilities of 1,811 clinical isolates of\n            <jats:italic>Cryptococcus neoformans<\/jats:italic>\n            obtained from 100 laboratories in 5 geographic regions worldwide between 1990 and 2004 were determined. The MICs of amphotericin B, flucytosine, fluconazole, voriconazole, posaconazole, and ravuconazole were determined by the National Committee for Clinical Laboratory Standards broth microdilution method. Isolates were submitted to a central reference laboratory (University of Iowa) from study centers in Africa (5 centers, 395 isolates), Europe (14 centers, 102 isolates), Latin America (14 centers, 82 isolates), the Pacific region (7 centers, 50 isolates), and North America (60 centers, 1,182 isolates). Resistance to amphotericin B, flucytosine, and fluconazole was \u22641% overall. Susceptibility to flucytosine (MIC, \u22644 \u03bcg\/ml) ranged from 35% in North America to 68% in Latin America. Similarly, only 75% of isolates from North America were susceptible to fluconazole (MIC, \u22648 \u03bcg\/ml) compared to 94 to 100% in the other regions. Isolates remained highly susceptible to amphotericin B (99% susceptibility at a MIC of \u22641 \u03bcg\/ml) over the entire 15-year period. Susceptibility to flucytosine (MIC, \u22644 \u03bcg\/ml) increased from 34% in 1990 to 1994 to 66% in 2000 to 2004. Susceptibility to fluconazole (MIC, \u22648 \u03bcg\/ml) increased from 72% in 1990 to 1994 to 96% in 2000 to 2004. Voriconazole, posaconazole, and ravuconazole all were very active (99% of isolates susceptible at MIC of \u22641 \u03bcg\/ml) against this geographically diverse collection of isolates. We conclude that in vitro resistance to antifungal agents used in the treatment of cryptococcosis remains uncommon among isolates of\n            <jats:italic>C. neoformans<\/jats:italic>\n            from five broad geographic regions and has not increased over a 15-year period.\n          <\/jats:p>","DOI":"10.1128\/jcm.43.5.2163-2167.2005","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T22:33:14Z","timestamp":1115245994000},"page":"2163-2167","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":179,"title":["Global Trends in the Antifungal Susceptibility of\n            <i>Cryptococcus neoformans<\/i>\n            (1990 to 2004)"],"prefix":"10.1128","volume":"43","author":[{"given":"M. A.","family":"Pfaller","sequence":"first","affiliation":[{"name":"Departments of Pathology"},{"name":"Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Messer","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Boyken","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rice","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tendolkar","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Hollis","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. V.","family":"Doern","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Diekema","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Medicine, Roy J. and Lucille A. Carver College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.6.1544-1548.2000"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46652001000500006"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.4.1179-1186.2003"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.4.1193-1199.2003"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3165-3169.2003"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1001.020779"},{"key":"e_1_3_2_8_2","first-page":"1337","volume":"23","year":"1996","unstructured":"Armengou, A., C. Pocar, J. Mascaro, and F. Garcia-Bragado. 1996. Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis. Clin. Infect. Dis.23:1337-1338.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_9_2","first-page":"186","volume":"26","year":"1998","unstructured":"Berg, J., C. J. Clancy, and M. H. Nguyen. 1998. The hidden danger of primary fluconazole prophylaxis for patients with AIDS. Clin. Infect. Dis.26:186-187.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/095646249500600510"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.4.812"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.11.3065-3069.2001"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-004-1136-2"},{"key":"e_1_3_2_14_2","first-page":"115","volume":"57","year":"2004","unstructured":"Chang, W.-N., C.-R. Huang, C.-B. Lei, P.-Y. Lee, C.-C. Chien, H.-W. Chang, C.-S. Chang, and C.-H. Lu. 2004. Serotypes of cerebrospinal fluid Cryptococcus neoformans isolates from Southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole. Jpn. J. Infect. Dis.57:115-117.","journal-title":"Jpn. J. Infect. Dis."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00011265"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019048-199507000-00019"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg399"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/42.2.217"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762003000600022"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-004-1108-6"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036195"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1086\/314606"},{"key":"e_1_3_2_23_2","first-page":"1693","year":"2003","unstructured":"Hazen, K. C., and S. A. Howell. 2003. Candida, Cryptococcus, and other yeasts of medical importance, p. 1693-1711. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.","journal-title":"Manual of clinical microbiology"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0703.017302"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1080\/mmy.40.5.519.523"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.12.3653-3656.1998"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.10.2817-2822.1998"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/515006"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/340522"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.515"},{"key":"e_1_3_2_31_2","unstructured":"National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution testing of yeasts. Approved standard 2nd ed. M27-A2. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_32_2","first-page":"673","volume":"31","year":"2002","unstructured":"Nesky, M. A., C. McDougal, and J. E. Peacock, Jr. 2002. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriosis. Clin. Infect. Dis.31:673-677.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.2.471"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1086\/322597"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/19.5.975-a"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/374557"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.3.857-869.2001"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.1.169"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2003.09.008"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.10.3551-3557.2002"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1470-9465.2004.t01-1-00844.x"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007376917836"},{"key":"e_1_3_2_43_2","first-page":"314","volume":"1","year":"1992","unstructured":"Powderly, W. G., E. J. Keath, M. Sokol-Anderson, K. Robinson, D. Kirtz, J. R. Little, and G. Kobayashi. 1992. Amphotericin B-resistant Cryptococcus neoformans in a patient with AIDS. Infect. Dis. Clin. Pract.1:314-316.","journal-title":"Infect. Dis. Clin. Pract."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1086\/313757"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh361"},{"key":"e_1_3_2_46_2","first-page":"663","volume":"97","year":"1997","unstructured":"Schwartz, S., D. Milatovic, and E. Thiel. 1997. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukemia. Br. J. Haematol.97:663-665.","journal-title":"Br. J. Haematol."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00981.x"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2883-2886.2000"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2002.00765.x"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.5.2163-2167.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.5.2163-2167.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:07:11Z","timestamp":1646453231000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.43.5.2163-2167.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1128\/JCM.43.5.2163-2167.2005"],"URL":"https:\/\/doi.org\/10.1128\/jcm.43.5.2163-2167.2005","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"2004-11-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-01-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}